The lingering threat of COVID-19 Confronting its burden in 2025
Supporting Families Optimizing Employee Fertility Benefits
Atopic Dermatitis in the Modern Era Assessing Patient Outcomes and Economic Burden
Advances in the Treatment of IgA Nephropathy
Update on RNA-Based Technology
Progress in Addressing Hyperlipidemia in the Primary Prevention Setting
Synergie Medication Collective Innovating for Medication Cost Savings
Demodex blepharitis: Navigating Diagnosis and Management Challenges
Understanding the Average Sales Price Landscape
Volume: 33
Issue: 10
